To offer the best possible experience tailored to your national regulatory requirements and the available product portfolio, please choose your country from the following list. This option will be saved throughout the browser session. Thank you!

GalliaPharm® Ge-68/Ga-68 generator receives approval for United Kingdom

Berlin, Germany

Eckert & Ziegler Radiopharma GmbH has been granted marketing authorization (PL 46734/0001) for GalliaPharm® from the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom. This important milestone makes GalliaPharm® available as a medicinal product in 13 European countries.

GalliaPharm® 68Ge/68Ga generator is a pharmaceutical product for the cyclotron-independent production of the positron emitter (68Ga) Gallium, giving a lot of flexibility when it comes to patient scheduling.  68Ga-labeled medicinal products are used in Positron Emission Tomography (PET) in the diagnosis of cancer.

The successful approval process makes GalliaPharm® the first 68Ge/68Ga generator registered as a medicinal product in the UK; thus, makes 68Ga available for use with SOMAKIT TOC® and clinical trials with [68Ga]Ga-PSMA-HBED-CC for PET diagnostics.

For more information about GalliaPharm® and its registration please contact our UK distributor Imaging Equipment Limited or fill the contact form below.


Get in touch

Contact us regarding your questions and we will get back to you as soon as possible.
By clicking send, you give your consent for processing your personal data in accordance with our Data Privacy Statement.